Phosphoenolpyruvate carboxykinase deficiency is a very rare inherited condition that affects how the body makes glucose, especially during fasting or illness. In babies and young children, early signs of Phosphoenolpyruvate carboxykinase deficiency can include low blood sugar, unusual sleepiness, vomiting, weakness, poor feeding, and an enlarged liver. Phosphoenolpyruvate carboxykinase deficiency usually begins early in life and can be lifelong, but not everyone will have the same experience. Some children become seriously ill during infections or long gaps without food, and severe episodes can be life threatening. Treatment focuses on preventing fasting, using frequent meals or overnight feeds, and giving prompt medical care during illness, often with support from a metabolic specialist.
How many people live with Phosphoenolpyruvate carboxykinase deficiency?
Worldwide, fewer than 20 people have been reported with phosphoenolpyruvate carboxykinase deficiency, which is the best available estimate for how many may be living with it globally (Genetic and Rare Diseases Information Center, 2024). A separate U.S. estimate is not consistently reported by a single authoritative source, so the exact number of people living with it in the United States is unknown.
Overview
Phosphoenolpyruvate carboxykinase deficiencySymptoms
Phosphoenolpyruvate carboxykinase deficiency often starts in infancy. Common features include low blood sugar, severe tiredness, poor feeding, vomiting, fast breathing, and an enlarged liver. Some babies may also have seizures or trouble growing.
Outlook and prognosis
Phosphoenolpyruvate carboxykinase deficiency can be serious, especially in infancy, with episodes of low blood sugar, acid buildup, and liver problems that may become life threatening. Outlook varies widely and is often better when episodes are recognized and treated early.
Causes and risk factors
Phosphoenolpyruvate carboxykinase deficiency is caused by harmful changes in the PCK1 or PCK2 gene, usually inherited from both parents. Most cases are not linked to lifestyle or environmental risks. Severity can vary.
Genetic influences
Genetics are central to phosphoenolpyruvate carboxykinase deficiency. It is caused by harmful changes in the PCK1 or PCK2 gene, and the exact variant can affect how severe symptoms are and when they start.
Diagnosis
Diagnosis of phosphoenolpyruvate carboxykinase deficiency usually starts with symptoms and lab findings such as low blood sugar and acid buildup, then is confirmed with genetic tests. Some children also need liver or imaging tests to rule out similar conditions.
Treatment and drugs
Treatment for phosphoenolpyruvate carboxykinase deficiency focuses on preventing low blood sugar and acid buildup with frequent meals, overnight feeds, and cornstarch in some children. During illness, many need urgent glucose and fluids in the hospital.
Symptoms
Phosphoenolpyruvate carboxykinase deficiency often becomes noticeable in newborns or infancy, especially during fasting or when a child is sick, because the body has trouble keeping blood sugar steady. Common features include episodes of low blood sugar, acid buildup in the blood, poor feeding, and trouble gaining weight. The early features of phosphoenolpyruvate carboxykinase deficiency can be mild in some children and severe in others. Features vary from person to person and can change over time.
Even short gaps between feeds can make a baby or child unwell because the body cannot make enough glucose between meals. This may show up as unusual sleepiness, irritability, sweating, weakness, or being hard to wake.
Low blood sugar is one of the most important signs and can happen during sleep, illness, or missed meals. In more serious episodes, children may vomit, seem limp, or have seizures.
The blood can become too acidic, a problem called lactic acidosis. This can cause fast or deep breathing, nausea or vomiting, and marked tiredness.
Many children have poor feeding, especially in infancy, and may tire easily during feeds. Over time, this can lead to slow weight gain or slower growth than expected.
How people usually first notice Phosphoenolpyruvate carboxykinase deficiency?
How phosphoenolpyruvate carboxykinase deficiency is first noticed often depends on the type, but many families first see a baby or young child become unusually sleepy, weak, or hard to wake during fasting, illness, or after going too long without food. Early first signs of phosphoenolpyruvate carboxykinase deficiency can also include low blood sugar, vomiting, poor feeding, rapid breathing, seizures, or an enlarged liver that a doctor may find on exam. In some children, growth problems or developmental delay lead to testing, but the condition is often first recognized when a serious metabolic crisis happens in infancy or early childhood.
Types of Phosphoenolpyruvate carboxykinase deficiency
No distinct types of Phosphoenolpyruvate carboxykinase deficiency are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes can truly delay when symptoms begin in phosphoenolpyruvate carboxykinase deficiency, because it is a rare inherited condition people are born with. What may help is careful day-to-day management, such as avoiding long gaps without food, following a feeding plan, and getting quick treatment during illness, which can lower the risk of low blood sugar and acid buildup episodes, but this is not the same as preventing the condition. Early care with a metabolic specialist and a clear sick-day emergency plan is the most established medical approach, and while it cannot promise a later onset, it can help many living with this condition stay safer.
What genetics can tell you about symptoms
Genetics can confirm the diagnosis, but for phosphoenolpyruvate carboxykinase deficiency they usually cannot predict symptoms with much precision because this condition is very rare and people can be affected in different ways. In general, disease-causing changes in the related gene can lower enzyme activity to different degrees, which may influence whether problems start in infancy or later and how severe low blood sugar, poor growth, tiredness, liver problems, or episodes during illness may be. Even so, many living with this condition do not follow a clear genetic pattern for symptoms, so doctors usually use both genetic results and day-to-day health findings to understand what to expect.
Causes and risk factors
Episodes often show up during fasting, vomiting, or an infection. The main cause of phosphoenolpyruvate carboxykinase deficiency is an inherited change in a gene that helps make the PEPCK enzyme. Most affected children inherit one nonworking copy from each parent, so family history or carrier parents raise the chance. Long gaps without food and dehydration do not cause the condition, but they can make symptoms start or get worse. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Phosphoenolpyruvate carboxykinase deficiency is almost always caused by rare inherited changes in a gene that helps the body keep blood sugar steady, especially during fasting. It usually happens only when a child inherits a nonworking copy from both parents, so the main risk factors are having carrier parents, a family history of the condition, or parents who are blood relatives, such as cousins. There are no well-known lifestyle or environmental causes.
Environmental and biological risk factors
For phosphoenolpyruvate carboxykinase deficiency, no well-established environmental or non-genetic biological risk factors have been identified. Some risks are carried inside the body, others come from the world around us, but this condition is not known to be linked to pregnancy exposures, infections, or routine day-to-day factors. This means there are no confirmed environmental or body-based risk factors to list here.
Genetic risk factors
For babies and children living with phosphoenolpyruvate carboxykinase deficiency, trouble keeping blood sugar stable during fasting usually begins with an inherited gene change present from birth. Most reported cases are linked to changes in the PCK1 gene, which helps the liver make glucose when the body has not eaten for a while. When families ask about the genetic causes of phosphoenolpyruvate carboxykinase deficiency, the key issue is usually whether both copies of this gene are affected. Carrying a genetic change doesn’t guarantee the condition will appear, because people with one altered copy are usually healthy carriers.
PCK1 changes: Most reported cases of phosphoenolpyruvate carboxykinase deficiency are caused by changes in the PCK1 gene. If both copies do not work properly, the body may struggle to make enough glucose during fasting.
Recessive inheritance: This condition usually follows an autosomal recessive inheritance pattern. That means a child is affected only after inheriting one altered copy of the gene from each parent.
Carrier parents: Parents who each carry one altered copy usually do not have symptoms themselves. With each pregnancy, there is a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy.
Family history: Having a brother, sister, or close relative with phosphoenolpyruvate carboxykinase deficiency raises the chance that the same gene change is present in the family. This can matter even when no one else seems affected, because carriers often feel completely well.
Related parents: When parents are biologically related, they are more likely to carry the same rare gene change. This increases the chance of recessive conditions like phosphoenolpyruvate carboxykinase deficiency in their children.
Lifestyle risk factors
Phosphoenolpyruvate carboxykinase deficiency is an inherited metabolic disorder, so lifestyle habits do not cause it. However, how lifestyle affects phosphoenolpyruvate carboxykinase deficiency can be important because daily routines may change the risk of hypoglycemia, acidosis, and metabolic decompensation. The main practical issues are avoiding long gaps without energy intake, matching activity to fuel availability, and responding quickly to stress on the body.
Long periods without food can trigger low blood sugar because the body has difficulty making enough glucose during fasting. Regular meals, snacks, and overnight feeding plans may reduce the risk of hypoglycemia and metabolic crisis.
Too little carbohydrate intake can leave the body without a reliable immediate fuel source. Consistent access to tolerated carbohydrates may help support energy needs and lower the chance of weakness, lethargy, or acidosis.
Prolonged or high-intensity exercise can increase energy demand faster than the body can compensate. Shorter, planned activity with fuel available before and after exercise may be safer and may help prevent hypoglycemia.
Vomiting, poor intake, fever, or diarrhea can quickly worsen dehydration and energy shortage in this condition. A sick-day plan with early carbohydrate support and medical guidance can help limit metabolic decompensation.
Risk prevention
Phosphoenolpyruvate carboxykinase deficiency is a rare inherited condition, so there is no proven way to prevent the condition itself if someone is born with it. Prevention usually means lowering the chance of dangerous low blood sugar, dehydration, and metabolic crises, especially during illness, poor feeding, or long gaps without food. Different people need different prevention strategies—there’s no single formula.
Long gaps without food can trigger low blood sugar and metabolic stress in people with phosphoenolpyruvate carboxykinase deficiency. Regular meals, planned snacks, and a sick-day feeding plan can help keep energy levels steadier.
Vomiting, diarrhea, fever, or infections can quickly make phosphoenolpyruvate carboxykinase deficiency harder to manage. Early fluids, extra carbohydrate as advised, and urgent medical care if intake is poor may help prevent a crisis.
Many living with phosphoenolpyruvate carboxykinase deficiency benefit from an emergency letter or care plan to bring to the hospital. This can help teams act quickly if early symptoms of phosphoenolpyruvate carboxykinase deficiency flare during an illness.
Regular visits with a metabolic specialist and dietitian can help adjust feeding schedules as a child grows or daily routines change. Prevention works best when combined with regular check-ups.
Can you prevent Phosphoenolpyruvate carboxykinase deficiency?
No, this condition usually cannot be prevented because it is an inherited condition, meaning a child is born with it if they receive the changed gene from both parents. If it runs in your family, talking with a genetics specialist before pregnancy can help you understand the chances of it happening and what testing options are available. Early diagnosis and regular care can help prevent some serious problems, but they do not stop the condition itself from occurring.
Transmission
Phosphoenolpyruvate carboxykinase deficiency is not infectious, so it does not spread from one person to another through the air, touch, food, sex, or everyday contact. It is a rare inherited metabolic condition, and how Phosphoenolpyruvate carboxykinase deficiency is inherited is usually through an autosomal recessive pattern, meaning a child gets one nonworking gene copy from each parent. Parents who carry one changed copy are often healthy themselves, but if both are carriers, each pregnancy has a 1 in 4, or 25%, chance of the child having Phosphoenolpyruvate carboxykinase deficiency. This chance is the same with every pregnancy.
When to test your genes
Consider genetic testing if a baby or child has unexplained low blood sugar, high lactic acid, liver enlargement, poor growth, or repeated metabolic crises, especially during fasting or illness. Testing is also important if there is a known family history or an affected sibling, because it can confirm the diagnosis and guide monitoring and fasting precautions.
Diagnosis
Phosphoenolpyruvate carboxykinase deficiency is usually diagnosed when a baby or child has episodes of low blood sugar, unusual sleepiness, fast breathing, or liver-related problems, especially during fasting or illness. Because these symptoms can overlap with other metabolic conditions, the diagnosis of phosphoenolpyruvate carboxykinase deficiency often combines the clinical picture with blood and urine testing, then confirmation with more specific studies. It’s natural to worry when symptoms don’t have a clear explanation.
Doctors start by looking closely at when symptoms happen, such as after longer gaps without feeding, during infections, or with vomiting and poor energy. A detailed family and health history can help show whether the pattern fits a rare inherited metabolic disorder.
Blood tests often show low blood sugar, especially during illness or fasting, and may also find acid buildup in the blood called lactic acidosis. Doctors usually check ketones, liver function, salts, and other lab tests to help rule out common conditions.
Specialized blood and urine tests look for chemical changes linked to problems making glucose, including abnormal levels of lactate, pyruvate, amino acids, and organic acids. These results can point doctors toward a disorder of gluconeogenesis, the pathway the body uses to keep blood sugar steady between meals.
Some children have an enlarged liver or abnormal liver blood tests, which can be picked up on physical exam and routine labs. Your provider may suggest an ultrasound to look closer and to check for other causes of liver enlargement.
How is Phosphoenolpyruvate carboxykinase deficiency diagnosed?
Doctors diagnose phosphoenolpyruvate carboxykinase deficiency by looking at the overall pattern, especially repeated episodes of very low blood sugar during fasting or illness, along with poor growth or liver problems, and matching this with blood and urine test results. These tests may show low blood sugar and a buildup of acids and other substances that suggest the body is having trouble making enough sugar between meals. The diagnosis is usually confirmed with genetic testing, and sometimes doctors also measure how well the affected enzyme is working.
Stages of Phosphoenolpyruvate carboxykinase deficiency
Phosphoenolpyruvate carboxykinase deficiency does not have defined progression stages. This is because it is usually a metabolic condition that causes episodes of low blood sugar, acid buildup, and weakness rather than a steady, predictable decline over time. Doctors usually start with a conversation about symptoms, such as the early symptoms of phosphoenolpyruvate carboxykinase deficiency in a baby or child, and then use blood and urine tests to look for changes linked to how the body makes and uses energy. Monitoring often focuses on how often these episodes happen, how severe they are, growth and development, and whether genetic testing confirms the diagnosis.
Outlook and prognosis
The outlook for phosphoenolpyruvate carboxykinase deficiency is highly variable, ranging from severe neonatal or infantile disease with recurrent hypoglycemia, lactic acidosis, and liver dysfunction to milder cases that survive into childhood or beyond. Prognosis is generally worse when episodes begin early, are frequent, or are complicated by prolonged fasting intolerance, seizures, or multiorgan involvement. Reported mortality is significant in the most severe forms, with some affected infants and young children dying from metabolic decompensation or related complications. In survivors, long-term problems can include developmental delay, poor growth, and recurrent illness, although outcomes may improve with early recognition and careful metabolic management. Because so few cases have been described, it is difficult to predict life expectancy precisely for any one person.
Long-term effects
Phosphoenolpyruvate carboxykinase deficiency can have very different long-term effects from one child to another. Some infants have a severe course early in life, while others who survive those first crises may go on to have ongoing problems with growth, development, and organ function. It’s important to remember that long-term doesn’t always mean progressive, but this condition can still place lasting stress on the brain, liver, and other tissues. When considering what lies ahead, doctors look closely at how often low blood sugar and acid buildup happen, since these episodes can shape long-term outcomes.
Repeated episodes of hypoglycemia can remain a major long-term risk in phosphoenolpyruvate carboxykinase deficiency, especially during illness or fasting. Over time, severe or repeated attacks may raise the chance of brain injury, seizures, or developmental problems.
Many living with phosphoenolpyruvate carboxykinase deficiency have recurrent episodes of lactic acidosis, when acid builds up in the blood faster than the body can clear it. These crises can be dangerous on their own and may add to long-term strain on major organs.
Poor weight gain and slower growth can continue over time, particularly in children with frequent metabolic crises. For many, this can mean delayed physical development and smaller body size than expected for age.
Some children have delays in sitting, walking, speech, learning, or school skills after early severe illness. The long-term picture is often shaped by how severe the early symptoms of phosphoenolpyruvate carboxykinase deficiency were and whether the brain was affected during metabolic episodes.
How is it to live with Phosphoenolpyruvate carboxykinase deficiency?
Living with phosphoenolpyruvate carboxykinase deficiency often means living with a body that struggles to keep blood sugar steady during fasting or illness, so daily life may revolve around regular meals, avoiding long gaps without food, and watching closely for signs like sleepiness, weakness, vomiting, or low energy. Many living with this condition need frequent medical follow-up, and some may have ongoing challenges such as poor growth, developmental delays, or episodes of metabolic crisis, especially during infections.
For families and other close supports, this can mean careful meal planning, overnight feeding schedules in some cases, and quick decisions when a child seems unwell, because minor illnesses can become serious faster than expected. Even so, with a clear care plan, prompt treatment during illness, and experienced metabolic care, many families find a rhythm that helps daily life feel more predictable and safer.
Treatment and drugs
Phosphoenolpyruvate carboxykinase deficiency is treated mainly by preventing low blood sugar and reducing stress on the body, since there is no simple cure that fixes the underlying enzyme problem. For many people, treatment begins with small daily steps, such as eating regularly, avoiding long gaps without food, and sometimes using overnight feeds or uncooked cornstarch to help keep blood sugar steady. During illness or times when eating is hard, people with phosphoenolpyruvate carboxykinase deficiency may need urgent hospital care with glucose and fluids to treat early symptoms of phosphoenolpyruvate carboxykinase deficiency, including low blood sugar, acid buildup, and dehydration. Long-term care is usually guided by a metabolic specialist and dietitian, who adjust the plan over time based on age, symptoms, growth, and how severe the condition is.
Can you cure Phosphoenolpyruvate carboxykinase deficiency?
No, there is currently no cure for phosphoenolpyruvate carboxykinase deficiency, a rare inherited condition that affects how the body makes and uses energy. Treatment aims to prevent low blood sugar and other body chemistry problems with frequent meals, avoiding long gaps without food, and careful care from a specialist, especially during illness. This can help manage symptoms and lower the risk of serious complications, but it does not remove the condition.
Non-drug treatment
Daily care for phosphoenolpyruvate carboxykinase deficiency usually centers on nutrition, preventing low blood sugar, and supporting growth and development. Managing this condition often means planning meals and snacks carefully so the body is not left without fuel for long stretches. Because symptoms and severity can vary, care is usually guided by a metabolic specialist, a dietitian, and other therapists as needed.
Regular meals and snacks are a main part of care because long gaps without food can trigger low blood sugar and acid buildup. Infants and young children may need feeds every few hours, including overnight.
Avoiding fasting is essential for many people with phosphoenolpyruvate carboxykinase deficiency, especially during infancy, illness, or periods of poor appetite. Families are usually taught how long it is safe to go without food at different ages.
A metabolic dietitian may recommend a diet that provides steady carbohydrate and enough overall calories to support growth. Some people also need adjusted protein or fat intake based on their symptoms, lab results, and the specific form of the condition.
Overnight feeding can help prevent dangerous drops in blood sugar while a child is asleep. This may be done with scheduled waking feeds, continuous tube feeds, or in some cases uncooked cornstarch if the care team recommends it.
Your genes may have an impact on how drugs work for you
For people living with phosphoenolpyruvate carboxykinase deficiency, treatment is usually built more around preventing low blood sugar and avoiding long gaps without food than around a regular set of medicines, so there is no well-established genetic test used to pick drugs for this condition. Even so, the underlying gene change can affect how the body handles energy, and many living with this condition may be more sensitive to medicines that strain the liver or make low blood sugar more likely. In day-to-day life, this means doctors often choose medicines carefully and watch closely for side effects, especially during illness, surgery, or times when eating is hard.
Pharmacological treatments
For phosphoenolpyruvate carboxykinase deficiency, there is no single approved medicine that corrects the underlying enzyme problem. Treatment mainly uses supportive medicines and hospital fluids to prevent or treat low blood sugar, acid buildup, and dehydration, especially during illness or fasting. Some medicines are only used in emergencies, while others may be used longer term depending on symptoms and lab results. Not everyone responds to the same medication in the same way, so treatment for phosphoenolpyruvate carboxykinase deficiency is usually tailored to the person.
Intravenous dextrose, and sometimes oral glucose, is used to raise blood sugar and reduce the body's stress response during metabolic crises. This is often a first treatment when early symptoms of phosphoenolpyruvate carboxykinase deficiency include poor feeding, unusual sleepiness, or vomiting.
Sodium bicarbonate may be given when acid builds up in the blood, a problem called metabolic acidosis. It is usually used in the hospital and guided closely by blood tests because too much or too little can be harmful.
Potassium may be needed if blood levels fall during illness, vomiting, or treatment with fluids and bicarbonate. Doctors choose the form and dose carefully because both low and high potassium can affect the heart and muscles.
If phosphoenolpyruvate carboxykinase deficiency leads to liver strain, doctors may use standard medicines aimed at the specific complication rather than the enzyme defect itself. In some cases, medicines are combined for symptom control, but there is no routine disease-specific drug that works for everyone.
Genetic influences
When a baby or child has trouble keeping blood sugar steady between feeds, the reason can sometimes be built into their genes. Most often, phosphoenolpyruvate carboxykinase deficiency is linked to changes in PCK1, the gene that helps the body make an enzyme used to produce glucose during fasting; more rarely, a related gene called PCK2 is involved. This means the genetic change is a direct cause of the condition, not just a background risk.
A carrier means you hold the gene change but may not show symptoms. Phosphoenolpyruvate carboxykinase deficiency is usually passed down in an autosomal recessive pattern, so if both parents are carriers, each pregnancy has a 25% chance of being affected. Testing the relevant gene can help confirm the diagnosis, and different gene changes can leave different amounts of enzyme activity, which may help explain why symptoms are not exactly the same in every family.
Is Phosphoenolpyruvate carboxykinase deficiency genetic?
Genetics are central to phosphoenolpyruvate carboxykinase deficiency. It is caused by harmful changes in the PCK1 or PCK2 gene, and the exact variant can affect how severe symptoms are and when they start.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common across the general population. Most of these variants do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with phosphoenolpyruvate carboxykinase deficiency, treatment is less about finding the right long-term drug and more about preventing low blood sugar and acid buildup, especially during illness or long gaps without food. The inherited gene change lowers the activity of an enzyme the body needs to make glucose at the right times, so care is usually built around frequent feeds, sick-day planning, and fast treatment if a metabolic crisis begins. There is not yet a medicine that can correct the gene change itself.
Genetics is only one factor, so doctors usually tailor treatment for phosphoenolpyruvate carboxykinase deficiency to symptoms, lab results, growth, and past episodes rather than to the DNA result alone. During severe episodes, hospital care may include glucose through an IV and sometimes treatment to bring acid levels back toward normal. In practice, genetic testing for phosphoenolpyruvate carboxykinase deficiency is most useful for confirming the diagnosis, guiding follow-up, and helping families understand recurrence risk, more than for choosing between different drugs.
Interactions with other conditions
People with phosphoenolpyruvate carboxykinase deficiency often become much sicker during common illnesses such as viral infections, stomach bugs, or any condition that causes poor eating, vomiting, diarrhea, or fever. When the body is under that kind of stress, blood sugar can drop and acid can build up more quickly, so the early symptoms of phosphoenolpyruvate carboxykinase deficiency may suddenly become more severe. Day-to-day, it can feel like one health issue amplifies the other, because even a short-lived illness can trigger dehydration, weakness, fast breathing, or confusion. Liver problems, kidney strain, or developmental and neurologic conditions may also make care more complicated, especially during hospital stays or recovery from another illness. Because treatment often depends on avoiding fasting and managing stress on the body, doctors usually watch closely for infections and other medical problems that could upset that balance.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Phosphoenolpyruvate carboxykinase deficiency?
Other rare conditions that affect how the body keeps blood sugar steady can look very similar, especially glycogen storage diseases and other inherited problems that make it hard to make sugar during fasting, such as fructose-1,6-bisphosphatase deficiency or pyruvate carboxylase deficiency. Doctors may also consider disorders that make it hard to use fat for energy, mitochondrial diseases that affect how cells make energy, severe liver disease, or serious infection, because these can also cause low blood sugar, acid buildup in the blood, weakness, and poor growth.
History
For families living with phosphoenolpyruvate carboxykinase deficiency, the condition can seem especially confusing because symptoms may come and go, often appearing during illness, fasting, or other times the body needs extra energy. That pattern shaped how doctors first recognized it. Early case reports focused on babies and children who developed low blood sugar, unusual sleepiness, weakness, or breathing changes, especially during metabolic stress, rather than on a single obvious sign present all the time.
Phosphoenolpyruvate carboxykinase deficiency began to appear in the medical literature in the second half of the 20th century, when better lab testing made it possible to link these episodes to problems in the body’s energy-making pathways. At first, doctors understood it mainly through symptoms and blood test findings, because the condition is rare and can look like several other metabolic disorders. In recent decades, awareness has grown, and that has helped clinicians recognize that the early symptoms of phosphoenolpyruvate carboxykinase deficiency may include repeated low blood sugar episodes, too much acid in the blood, or poor feeding in infants.
As medical science evolved, researchers were able to study the enzyme involved more directly and later confirmed that phosphoenolpyruvate carboxykinase deficiency has a genetic cause. That shift mattered because it moved the condition from being described only as a puzzling group of metabolic crises to being understood as a specific inherited disorder. Not every early description was complete, yet together they helped build the picture doctors use today.
The history of phosphoenolpyruvate carboxykinase deficiency is still relatively short compared with more common conditions, and much of what has been learned has come from carefully studying small numbers of affected families over time. Because it is so uncommon, knowledge has grown step by step. For many living with phosphoenolpyruvate carboxykinase deficiency, that history helps explain why diagnosis may take time and why care today often depends on both clinical experience and specialized metabolic testing.